Spots Global Cancer Trial Database for Molecular Tumor Board at the Center for Personalized Medicine Tübingen
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Molecular Tumor Board at the Center for Personalized Medicine Tübingen
Official Title: Molecular Tumor Board at the Center for Personalized Medicine Tübingen: a Prospective Observational Study
Study ID: NCT03503149
Conditions
Interventions
Study Description
Brief Summary: Molecular Tumor Board at the Center for Personalized Medicine
Detailed Description: Molecular Tumor Board at the Center for Personalized Medicine The study objectives are * To ensure a prospective documentation of all patients who are referred to the Molecular Tumor Board in routine clinical care * To prospectively ensure the documentation of MTB patients with an emphasis to clinical outcome parameters progression-free survival (PFS), overall survival (OS) and further response assessments (e.g. peripheral immunmonitoring, imaging parameters) * To prospectively assess patient-reported outcome of MTB patients * To evaluate compliance to MTB suggestions in routine clinical care
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University Hospital Tübingen, Tübingen, BW, Germany
Contact Details
Name: Ghazaleh Tabatabai, Prof
Affiliation: University Hospital Tübingen
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
